Skip to main content
. 2015 Mar 24;50(1):19–25. doi: 10.5045/br.2015.50.1.19

Table 2. Therapeutic responses to eltrombopag.

graphic file with name br-50-19-i002.jpg

a)Initial required doses to achieve target platelet count (≥50,000 cells/mL, N=13). b)Doses to maintain target platelet count (≥ 50,000 cells/mL, N=13).

Abbreviations: EOD, every other day; RFS, relapse-free survival.